Cargando…
Percutaneous fiducial marker placement under CT fluoroscopic guidance for stereotactic body radiotherapy of the lung: an initial experience
The aim of this study is to describe our initial experience with the VISICOIL, which is the first percutaneous fiducial marker approved for stereotactic body radiotherapy in Japan, and to evaluate its technical and clinical efficacy, and safety. Eight patients underwent this procedure under CT fluor...
Autores principales: | Ohta, Kengo, Shimohira, Masashi, Iwata, Hiromitsu, Hashizume, Takuya, Ogino, Hiroyuki, Miyakawa, Akifumi, Murai, Taro, Shibamoto, Yuta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766292/ https://www.ncbi.nlm.nih.gov/pubmed/23608462 http://dx.doi.org/10.1093/jrr/rrt020 |
Ejemplares similares
-
Percutaneous fiducial marker placement prior to stereotactic body radiotherapy for malignant liver tumors: an initial experience
por: Ohta, Kengo, et al.
Publicado: (2016) -
Organizing pneumonia after stereotactic ablative radiotherapy of the lung
por: Murai, Taro, et al.
Publicado: (2012) -
Radiobiology of hypofractionated stereotactic radiotherapy: what are the optimal fractionation schedules?
por: Shibamoto, Yuta, et al.
Publicado: (2016) -
Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size
por: Baba, Fumiya, et al.
Publicado: (2010) -
Changes in pulmonary function and their correlation with dose–volume parameters in patients undergoing stereotactic body radiotherapy for lung cancer
por: Takemoto, Shinya, et al.
Publicado: (2021)